The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chronic Constipation Treatment Drugs Market Research Report 2025
Synopsis
The global Chronic Constipation Treatment Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Constipation Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Constipation Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chronic Constipation Treatment Drugs include Pfizer, Ardelyx, Norgine, Takeda Pharmaceuticals, Ironwood Pharmaceuticals, Synergy Pharmaceuticals, Salix Pharmaceuticals, Shire Pharmaceuticals and Allergan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Constipation Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Constipation Treatment Drugs.
Report Scope
The Chronic Constipation Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Constipation Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Constipation Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Ardelyx
Norgine
Takeda Pharmaceuticals
Ironwood Pharmaceuticals
Synergy Pharmaceuticals
Salix Pharmaceuticals
Shire Pharmaceuticals
Allergan
Renexxion
Sucampo Pharmaceuticals
Shionogi
Teva Pharmaceuticals
RedHill Biopharma
Ferring Pharmaceuticals
Theravance Biopharma
Progenity Inc.
Synthetic Biologics
Progenics Pharmaceuticals
Segment by Type
Serotonin-4 (5-Ht4) Receptor Agonist
Guanylate Cyclase-C Agonist
Laxatives
Stimulants
Others
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Constipation Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Constipation Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Chronic Constipation Treatment Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Constipation Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Constipation Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chronic Constipation Treatment Drugs include Pfizer, Ardelyx, Norgine, Takeda Pharmaceuticals, Ironwood Pharmaceuticals, Synergy Pharmaceuticals, Salix Pharmaceuticals, Shire Pharmaceuticals and Allergan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Constipation Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Constipation Treatment Drugs.
Report Scope
The Chronic Constipation Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Constipation Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Constipation Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Ardelyx
Norgine
Takeda Pharmaceuticals
Ironwood Pharmaceuticals
Synergy Pharmaceuticals
Salix Pharmaceuticals
Shire Pharmaceuticals
Allergan
Renexxion
Sucampo Pharmaceuticals
Shionogi
Teva Pharmaceuticals
RedHill Biopharma
Ferring Pharmaceuticals
Theravance Biopharma
Progenity Inc.
Synthetic Biologics
Progenics Pharmaceuticals
Segment by Type
Serotonin-4 (5-Ht4) Receptor Agonist
Guanylate Cyclase-C Agonist
Laxatives
Stimulants
Others
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Constipation Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Constipation Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chronic Constipation Treatment Drugs Market Overview
1.1 Product Overview and Scope of Chronic Constipation Treatment Drugs
1.2 Chronic Constipation Treatment Drugs Segment by Type
1.2.1 Global Chronic Constipation Treatment Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Serotonin-4 (5-Ht4) Receptor Agonist
1.2.3 Guanylate Cyclase-C Agonist
1.2.4 Laxatives
1.2.5 Stimulants
1.2.6 Others
1.3 Chronic Constipation Treatment Drugs Segment by Application
1.3.1 Global Chronic Constipation Treatment Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Chronic Constipation Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Chronic Constipation Treatment Drugs Revenue 2019-2030
1.4.2 Global Chronic Constipation Treatment Drugs Sales 2019-2030
1.4.3 Global Chronic Constipation Treatment Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chronic Constipation Treatment Drugs Market Competition by Manufacturers
2.1 Global Chronic Constipation Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chronic Constipation Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chronic Constipation Treatment Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Chronic Constipation Treatment Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chronic Constipation Treatment Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Constipation Treatment Drugs, Product Type & Application
2.7 Chronic Constipation Treatment Drugs Market Competitive Situation and Trends
2.7.1 Chronic Constipation Treatment Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chronic Constipation Treatment Drugs Players Market Share by Revenue
2.7.3 Global Chronic Constipation Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Constipation Treatment Drugs Retrospective Market Scenario by Region
3.1 Global Chronic Constipation Treatment Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chronic Constipation Treatment Drugs Global Chronic Constipation Treatment Drugs Sales by Region: 2019-2030
3.2.1 Global Chronic Constipation Treatment Drugs Sales by Region: 2019-2024
3.2.2 Global Chronic Constipation Treatment Drugs Sales by Region: 2025-2030
3.3 Global Chronic Constipation Treatment Drugs Global Chronic Constipation Treatment Drugs Revenue by Region: 2019-2030
3.3.1 Global Chronic Constipation Treatment Drugs Revenue by Region: 2019-2024
3.3.2 Global Chronic Constipation Treatment Drugs Revenue by Region: 2025-2030
3.4 North America Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.4.1 North America Chronic Constipation Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chronic Constipation Treatment Drugs Sales by Country (2019-2030)
3.4.3 North America Chronic Constipation Treatment Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.5.1 Europe Chronic Constipation Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chronic Constipation Treatment Drugs Sales by Country (2019-2030)
3.5.3 Europe Chronic Constipation Treatment Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Chronic Constipation Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chronic Constipation Treatment Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Chronic Constipation Treatment Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.7.1 Latin America Chronic Constipation Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chronic Constipation Treatment Drugs Sales by Country (2019-2030)
3.7.3 Latin America Chronic Constipation Treatment Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chronic Constipation Treatment Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Constipation Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chronic Constipation Treatment Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chronic Constipation Treatment Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Constipation Treatment Drugs Sales by Type (2019-2030)
4.1.1 Global Chronic Constipation Treatment Drugs Sales by Type (2019-2024)
4.1.2 Global Chronic Constipation Treatment Drugs Sales by Type (2025-2030)
4.1.3 Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2019-2030)
4.2 Global Chronic Constipation Treatment Drugs Revenue by Type (2019-2030)
4.2.1 Global Chronic Constipation Treatment Drugs Revenue by Type (2019-2024)
4.2.2 Global Chronic Constipation Treatment Drugs Revenue by Type (2025-2030)
4.2.3 Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Chronic Constipation Treatment Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chronic Constipation Treatment Drugs Sales by Application (2019-2030)
5.1.1 Global Chronic Constipation Treatment Drugs Sales by Application (2019-2024)
5.1.2 Global Chronic Constipation Treatment Drugs Sales by Application (2025-2030)
5.1.3 Global Chronic Constipation Treatment Drugs Sales Market Share by Application (2019-2030)
5.2 Global Chronic Constipation Treatment Drugs Revenue by Application (2019-2030)
5.2.1 Global Chronic Constipation Treatment Drugs Revenue by Application (2019-2024)
5.2.2 Global Chronic Constipation Treatment Drugs Revenue by Application (2025-2030)
5.2.3 Global Chronic Constipation Treatment Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Chronic Constipation Treatment Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Chronic Constipation Treatment Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Ardelyx
6.2.1 Ardelyx Corporation Information
6.2.2 Ardelyx Description and Business Overview
6.2.3 Ardelyx Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ardelyx Chronic Constipation Treatment Drugs Product Portfolio
6.2.5 Ardelyx Recent Developments/Updates
6.3 Norgine
6.3.1 Norgine Corporation Information
6.3.2 Norgine Description and Business Overview
6.3.3 Norgine Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Norgine Chronic Constipation Treatment Drugs Product Portfolio
6.3.5 Norgine Recent Developments/Updates
6.4 Takeda Pharmaceuticals
6.4.1 Takeda Pharmaceuticals Corporation Information
6.4.2 Takeda Pharmaceuticals Description and Business Overview
6.4.3 Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.4.5 Takeda Pharmaceuticals Recent Developments/Updates
6.5 Ironwood Pharmaceuticals
6.5.1 Ironwood Pharmaceuticals Corporation Information
6.5.2 Ironwood Pharmaceuticals Description and Business Overview
6.5.3 Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.5.5 Ironwood Pharmaceuticals Recent Developments/Updates
6.6 Synergy Pharmaceuticals
6.6.1 Synergy Pharmaceuticals Corporation Information
6.6.2 Synergy Pharmaceuticals Description and Business Overview
6.6.3 Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.6.5 Synergy Pharmaceuticals Recent Developments/Updates
6.7 Salix Pharmaceuticals
6.6.1 Salix Pharmaceuticals Corporation Information
6.6.2 Salix Pharmaceuticals Description and Business Overview
6.6.3 Salix Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Salix Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.7.5 Salix Pharmaceuticals Recent Developments/Updates
6.8 Shire Pharmaceuticals
6.8.1 Shire Pharmaceuticals Corporation Information
6.8.2 Shire Pharmaceuticals Description and Business Overview
6.8.3 Shire Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shire Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.8.5 Shire Pharmaceuticals Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Corporation Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Allergan Chronic Constipation Treatment Drugs Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Renexxion
6.10.1 Renexxion Corporation Information
6.10.2 Renexxion Description and Business Overview
6.10.3 Renexxion Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Renexxion Chronic Constipation Treatment Drugs Product Portfolio
6.10.5 Renexxion Recent Developments/Updates
6.11 Sucampo Pharmaceuticals
6.11.1 Sucampo Pharmaceuticals Corporation Information
6.11.2 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Description and Business Overview
6.11.3 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.11.5 Sucampo Pharmaceuticals Recent Developments/Updates
6.12 Shionogi
6.12.1 Shionogi Corporation Information
6.12.2 Shionogi Chronic Constipation Treatment Drugs Description and Business Overview
6.12.3 Shionogi Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shionogi Chronic Constipation Treatment Drugs Product Portfolio
6.12.5 Shionogi Recent Developments/Updates
6.13 Teva Pharmaceuticals
6.13.1 Teva Pharmaceuticals Corporation Information
6.13.2 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Description and Business Overview
6.13.3 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Teva Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.13.5 Teva Pharmaceuticals Recent Developments/Updates
6.14 RedHill Biopharma
6.14.1 RedHill Biopharma Corporation Information
6.14.2 RedHill Biopharma Chronic Constipation Treatment Drugs Description and Business Overview
6.14.3 RedHill Biopharma Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 RedHill Biopharma Chronic Constipation Treatment Drugs Product Portfolio
6.14.5 RedHill Biopharma Recent Developments/Updates
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Corporation Information
6.15.2 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Description and Business Overview
6.15.3 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments/Updates
6.16 Theravance Biopharma
6.16.1 Theravance Biopharma Corporation Information
6.16.2 Theravance Biopharma Chronic Constipation Treatment Drugs Description and Business Overview
6.16.3 Theravance Biopharma Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Theravance Biopharma Chronic Constipation Treatment Drugs Product Portfolio
6.16.5 Theravance Biopharma Recent Developments/Updates
6.17 Progenity Inc.
6.17.1 Progenity Inc. Corporation Information
6.17.2 Progenity Inc. Chronic Constipation Treatment Drugs Description and Business Overview
6.17.3 Progenity Inc. Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Progenity Inc. Chronic Constipation Treatment Drugs Product Portfolio
6.17.5 Progenity Inc. Recent Developments/Updates
6.18 Synthetic Biologics
6.18.1 Synthetic Biologics Corporation Information
6.18.2 Synthetic Biologics Chronic Constipation Treatment Drugs Description and Business Overview
6.18.3 Synthetic Biologics Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Synthetic Biologics Chronic Constipation Treatment Drugs Product Portfolio
6.18.5 Synthetic Biologics Recent Developments/Updates
6.19 Progenics Pharmaceuticals
6.19.1 Progenics Pharmaceuticals Corporation Information
6.19.2 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Description and Business Overview
6.19.3 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Product Portfolio
6.19.5 Progenics Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Constipation Treatment Drugs Industry Chain Analysis
7.2 Chronic Constipation Treatment Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Constipation Treatment Drugs Production Mode & Process
7.4 Chronic Constipation Treatment Drugs Sales and Marketing
7.4.1 Chronic Constipation Treatment Drugs Sales Channels
7.4.2 Chronic Constipation Treatment Drugs Distributors
7.5 Chronic Constipation Treatment Drugs Customers
8 Chronic Constipation Treatment Drugs Market Dynamics
8.1 Chronic Constipation Treatment Drugs Industry Trends
8.2 Chronic Constipation Treatment Drugs Market Drivers
8.3 Chronic Constipation Treatment Drugs Market Challenges
8.4 Chronic Constipation Treatment Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chronic Constipation Treatment Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chronic Constipation Treatment Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chronic Constipation Treatment Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chronic Constipation Treatment Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Chronic Constipation Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chronic Constipation Treatment Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chronic Constipation Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chronic Constipation Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chronic Constipation Treatment Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chronic Constipation Treatment Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Chronic Constipation Treatment Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Constipation Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Constipation Treatment Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Constipation Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chronic Constipation Treatment Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Chronic Constipation Treatment Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Chronic Constipation Treatment Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Chronic Constipation Treatment Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Chronic Constipation Treatment Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chronic Constipation Treatment Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Chronic Constipation Treatment Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chronic Constipation Treatment Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Chronic Constipation Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chronic Constipation Treatment Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Chronic Constipation Treatment Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Chronic Constipation Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chronic Constipation Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chronic Constipation Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chronic Constipation Treatment Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Chronic Constipation Treatment Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Chronic Constipation Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chronic Constipation Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chronic Constipation Treatment Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chronic Constipation Treatment Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Chronic Constipation Treatment Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Chronic Constipation Treatment Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chronic Constipation Treatment Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chronic Constipation Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chronic Constipation Treatment Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Chronic Constipation Treatment Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Chronic Constipation Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chronic Constipation Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chronic Constipation Treatment Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chronic Constipation Treatment Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Chronic Constipation Treatment Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Chronic Constipation Treatment Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chronic Constipation Treatment Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chronic Constipation Treatment Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Chronic Constipation Treatment Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Chronic Constipation Treatment Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Chronic Constipation Treatment Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Chronic Constipation Treatment Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Chronic Constipation Treatment Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Chronic Constipation Treatment Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Chronic Constipation Treatment Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chronic Constipation Treatment Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chronic Constipation Treatment Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Chronic Constipation Treatment Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Chronic Constipation Treatment Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Ardelyx Corporation Information
Table 76. Ardelyx Description and Business Overview
Table 77. Ardelyx Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Ardelyx Chronic Constipation Treatment Drugs Product
Table 79. Ardelyx Recent Developments/Updates
Table 80. Norgine Corporation Information
Table 81. Norgine Description and Business Overview
Table 82. Norgine Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Norgine Chronic Constipation Treatment Drugs Product
Table 84. Norgine Recent Developments/Updates
Table 85. Takeda Pharmaceuticals Corporation Information
Table 86. Takeda Pharmaceuticals Description and Business Overview
Table 87. Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Takeda Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 89. Takeda Pharmaceuticals Recent Developments/Updates
Table 90. Ironwood Pharmaceuticals Corporation Information
Table 91. Ironwood Pharmaceuticals Description and Business Overview
Table 92. Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Ironwood Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 94. Ironwood Pharmaceuticals Recent Developments/Updates
Table 95. Synergy Pharmaceuticals Corporation Information
Table 96. Synergy Pharmaceuticals Description and Business Overview
Table 97. Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Synergy Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 99. Synergy Pharmaceuticals Recent Developments/Updates
Table 100. Salix Pharmaceuticals Corporation Information
Table 101. Salix Pharmaceuticals Description and Business Overview
Table 102. Salix Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Salix Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 104. Salix Pharmaceuticals Recent Developments/Updates
Table 105. Shire Pharmaceuticals Corporation Information
Table 106. Shire Pharmaceuticals Description and Business Overview
Table 107. Shire Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Shire Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 109. Shire Pharmaceuticals Recent Developments/Updates
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Business Overview
Table 112. Allergan Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Allergan Chronic Constipation Treatment Drugs Product
Table 114. Allergan Recent Developments/Updates
Table 115. Renexxion Corporation Information
Table 116. Renexxion Description and Business Overview
Table 117. Renexxion Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Renexxion Chronic Constipation Treatment Drugs Product
Table 119. Renexxion Recent Developments/Updates
Table 120. Sucampo Pharmaceuticals Corporation Information
Table 121. Sucampo Pharmaceuticals Description and Business Overview
Table 122. Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sucampo Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 124. Sucampo Pharmaceuticals Recent Developments/Updates
Table 125. Shionogi Corporation Information
Table 126. Shionogi Description and Business Overview
Table 127. Shionogi Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Shionogi Chronic Constipation Treatment Drugs Product
Table 129. Shionogi Recent Developments/Updates
Table 130. Teva Pharmaceuticals Corporation Information
Table 131. Teva Pharmaceuticals Description and Business Overview
Table 132. Teva Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Teva Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 134. Teva Pharmaceuticals Recent Developments/Updates
Table 135. RedHill Biopharma Corporation Information
Table 136. RedHill Biopharma Description and Business Overview
Table 137. RedHill Biopharma Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. RedHill Biopharma Chronic Constipation Treatment Drugs Product
Table 139. RedHill Biopharma Recent Developments/Updates
Table 140. Ferring Pharmaceuticals Corporation Information
Table 141. Ferring Pharmaceuticals Description and Business Overview
Table 142. Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Ferring Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 144. Ferring Pharmaceuticals Recent Developments/Updates
Table 145. Theravance Biopharma Corporation Information
Table 146. Theravance Biopharma Description and Business Overview
Table 147. Theravance Biopharma Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Theravance Biopharma Chronic Constipation Treatment Drugs Product
Table 149. Theravance Biopharma Recent Developments/Updates
Table 150. Progenity Inc. Corporation Information
Table 151. Progenity Inc. Description and Business Overview
Table 152. Progenity Inc. Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Progenity Inc. Chronic Constipation Treatment Drugs Product
Table 154. Progenity Inc. Recent Developments/Updates
Table 155. Synthetic Biologics Corporation Information
Table 156. Synthetic Biologics Description and Business Overview
Table 157. Synthetic Biologics Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Synthetic Biologics Chronic Constipation Treatment Drugs Product
Table 159. Synthetic Biologics Recent Developments/Updates
Table 160. Progenics Pharmaceuticals Corporation Information
Table 161. Progenics Pharmaceuticals Description and Business Overview
Table 162. Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Progenics Pharmaceuticals Chronic Constipation Treatment Drugs Product
Table 164. Progenics Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Chronic Constipation Treatment Drugs Distributors List
Table 168. Chronic Constipation Treatment Drugs Customers List
Table 169. Chronic Constipation Treatment Drugs Market Trends
Table 170. Chronic Constipation Treatment Drugs Market Drivers
Table 171. Chronic Constipation Treatment Drugs Market Challenges
Table 172. Chronic Constipation Treatment Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chronic Constipation Treatment Drugs
Figure 2. Global Chronic Constipation Treatment Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chronic Constipation Treatment Drugs Market Share by Type in 2023 & 2030
Figure 4. Serotonin-4 (5-Ht4) Receptor Agonist Product Picture
Figure 5. Guanylate Cyclase-C Agonist Product Picture
Figure 6. Laxatives Product Picture
Figure 7. Stimulants Product Picture
Figure 8. Others Product Picture
Figure 9. Global Chronic Constipation Treatment Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Chronic Constipation Treatment Drugs Market Share by Application in 2023 & 2030
Figure 11. Hospitals
Figure 12. Homecare
Figure 13. Specialty Clinics
Figure 14. Others
Figure 15. Global Chronic Constipation Treatment Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Chronic Constipation Treatment Drugs Market Size (2019-2030) & (US$ Million)
Figure 17. Global Chronic Constipation Treatment Drugs Sales (2019-2030) & (K Units)
Figure 18. Global Chronic Constipation Treatment Drugs Average Price (US$/Unit) & (2019-2030)
Figure 19. Chronic Constipation Treatment Drugs Report Years Considered
Figure 20. Chronic Constipation Treatment Drugs Sales Share by Manufacturers in 2023
Figure 21. Global Chronic Constipation Treatment Drugs Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Chronic Constipation Treatment Drugs Players: Market Share by Revenue in 2023
Figure 23. Chronic Constipation Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Chronic Constipation Treatment Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Chronic Constipation Treatment Drugs Sales Market Share by Country (2019-2030)
Figure 26. North America Chronic Constipation Treatment Drugs Revenue Market Share by Country (2019-2030)
Figure 27. United States Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Chronic Constipation Treatment Drugs Sales Market Share by Country (2019-2030)
Figure 30. Europe Chronic Constipation Treatment Drugs Revenue Market Share by Country (2019-2030)
Figure 31. Germany Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Netherlands Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Chronic Constipation Treatment Drugs Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Chronic Constipation Treatment Drugs Revenue Market Share by Region (2019-2030)
Figure 38. China Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Chronic Constipation Treatment Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Chronic Constipation Treatment Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Chronic Constipation Treatment Drugs Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Chronic Constipation Treatment Drugs Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Chronic Constipation Treatment Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Chronic Constipation Treatment Drugs by Type (2019-2030)
Figure 57. Global Revenue Market Share of Chronic Constipation Treatment Drugs by Type (2019-2030)
Figure 58. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Chronic Constipation Treatment Drugs by Application (2019-2030)
Figure 60. Global Revenue Market Share of Chronic Constipation Treatment Drugs by Application (2019-2030)
Figure 61. Global Chronic Constipation Treatment Drugs Price (US$/Unit) by Application (2019-2030)
Figure 62. Chronic Constipation Treatment Drugs Value Chain
Figure 63. Chronic Constipation Treatment Drugs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
